Related Experiment Videos
Meningococcal purpura fulminans treated with antithrombin III concentrate: what is the optimal replacement therapy?
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A Genome-wide Visual Screen Identifies Lysophosphatidylcholine as Counter Spatial Regulator of DAG and Sterols in Yeast.
bioRxiv : the preprint server for biology·2026
Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047).
Annals of oncology : official journal of the European Society for Medical Oncology·2024
How to estimate stone volume and its use in stone surgery: a comprehensive review.
Actas urologicas espanolas·2023
Ablation rates with Holmium:YAG and Thulium Fiber Laser: Influence of the stone phantom homogeneity. An in vitro study.
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
A serological re-evaluation of acute non-A non-B hepatitis from the early 1970s.
Australian and New Zealand journal of medicine·2001
Cost-effectiveness and accuracy of exercise stress echocardiography in the non-invasive diagnosis of coronary heart disease.
Australian and New Zealand journal of medicine·2001
A multivariate analysis of the association between social class of origin and current social class with self-rated general health and psychological health among 16-year-old Australians.
Australian and New Zealand journal of medicine·2001
Phaeochromocytomas discovered during coronial autopsies in Sydney, Melbourne and Auckland.
Australian and New Zealand journal of medicine·2001
Association of Time of Day With Functional Outcome in Intracerebral Hemorrhage.
European journal of neurology·2026
Development of CRISPR_SCD001, an Autologous Hematopoietic Stem Cell Gene Therapy for Sickle Cell Disease after CRISPR-Cas9 Mediated Correction.
Molecular therapy : the journal of the American Society of Gene Therapy·2026
A new player in hemolytic uremic syndrome: the plasma kallikrein-kinin system, a target of heme.
Kidney international·2026